Brain imaging and networks in restless legs syndrome

Sleep Medicine

Volumn 31, Issue , 2017, Pages 39-48

  Rizzo, Giovanni ^a,b   Li, Xu ^c,d   Galantucci, Sebastiano ^e   Filippi, Massimo ^e   Cho, Yong Won ^f  

^a BELLARIA HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c KENNEDY KRIEGER INSTITUTE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f Dongsan Medical Center   (South Korea)

Author keywords

Connectivity; Imaging; MRI; Network; Pathophysiology; Restless legs syndrome

Indexed keywords

RADIOPHARMACEUTICAL AGENT;

BRAIN BLOOD FLOW; BRAIN LEVEL; BRAIN MAPPING; BRAIN METABOLISM; BRAIN RADIOGRAPHY; CONNECTOME; DIFFUSION TENSOR IMAGING; DOPAMINERGIC SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LIMBIC SYSTEM; NERVE CELL NETWORK; NEUROTRANSMITTER RELEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; RESTLESS LEGS SYNDROME; REVIEW; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SUBSTANTIA NIGRA; VOLUMETRY; VOXEL BASED MORPHOMETRY; WHITE MATTER; ANIMAL; BRAIN; DIAGNOSTIC IMAGING; NERVE TRACT; NEUROIMAGING; PATHOPHYSIOLOGY;

ANIMALS; BRAIN; HUMANS; NEURAL PATHWAYS; NEUROIMAGING; RESTLESS LEGS SYNDROME;

EID: 85013932828     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2016.07.018     Document Type: Review

References (132)

1. [1] Lu, F.M., Yuan, Z., PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases. Quant Imaging Med Surg 5 (2015), 433–447.
2. [2] Camargo, E.E., Brain SPECT in neurology and psychiatry. J Nucl Med 42 (2001), 611–623.
3. [3] Zhu, L., Ploessl, K., Kung, H.F., PET/SPECT imaging agents for neurodegenerative diseases. Chem Soc Rev 43 (2014), 6683–6691.
4. [4] Shen, L.H., Liao, M.H., Tseng, Y.C., Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders. J Biomed Biotechnol, 2012, 2012 259349.
5. [5] Brooks, D.J., Pavese, N., Imaging biomarkers in Parkinson's disease. Prog Neurobiol 95 (2011), 614–628.
6. [6] Pappatà, S., Salvatore, E., Postiglione, A., In vivo imaging of neurotransmission and brain receptors in dementia. J Neuroimaging 18 (2008), 111–124.
7. 11C-ABP688. J Nucl Med 48 (2007), 247–252.
8. [8] McConathy, J., Kilts, C.D., Goodman, M.M., Radioligands for PET and SPECT imaging of the central noradrenergic system. CNS Spectr 6 (2001), 704–709.
9. [9] Lehto, J., Hirvonen, M.M., Johansson, J., et al. Validation of [(11)C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain. Synapse 69 (2015), 172–181.
10. 11C-yohimbine. J Nucl Med 56 (2015), 392–398.
11. [11] Haacke, E.M., Cheng, N.Y., House, M.J., et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 23 (2005), 1–25.
12. [12] Schenck, J.F., Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths. J Neurol Sci 134 Suppl (1995), 10–18.
13. [13] Graham, J.M., Paley, M.N., Grunewald, R.A., et al. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 123 (2000), 2423–2431.
14. [14] Bartzokis, G., Aravagiri, M., Oldendorf, W.H., et al. Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med 29 (1993), 459–464.
15. [15] Bartzokis, G., Tishler, T.A., MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell Mol Biol (Noisy-Le-Grand) 46 (2000), 821–833.
16. [16] Jensen, J.H., Chandra, R., Ramani, A., et al. Magnetic field correlation imaging. Magn Reson Med 55 (2006), 1350–1361.
17. [17] Jensen, J.H., Szulc, K., Hu, C., et al. Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magn Reson Med 61 (2009), 481–485.
18. [18] Ogg, R.J., Langston, J.W., Haacke, E.M., et al. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 17 (1999), 1141–1148.
19. [19] Haacke, E.M., Xu, Y., Cheng, Y.C., et al. Susceptibility weighted imaging (SWI). Magn Reson Med 52 (2004), 612–618.
20. [20] Smith, S.A., Bulte, J.W., van Zijl, P.C., Direct saturation MRI: theory and application to imaging brain iron. Magn Reson Med 62 (2009), 384–393.
21. [21] Wang, Y., Liu, T., Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn Reson Med 73 (2015), 82–101.
22. [22] Liu, C., Li, W., Tong, K.A., et al. Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J Magn Reson Imaging 42 (2015), 23–41.
23. [23] Langkammer, C., Ropele, S., Pirpamer, L., et al. MRI for iron mapping in Alzheimer's disease. Neurodegener Dis 13 (2014), 189–191.
24. [24] Hallgren, B., Sourander, P., The effect of age on the non-haemin iron in the human brain. J Neurochem 3 (1958), 41–51.
25. [25] Langkammer, C., Krebs, N., Goessler, W., et al. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 257 (2010), 455–462.
26. [26] Langkammer, C., Schweser, F., Krebs, N., et al. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 62 (2012), 1593–1599.
27. [27] Lim, I.A., Faria, A.V., Li, X., et al. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures. Neuroimage 82 (2013), 449–469.
28. [28] Zheng, W., Nichol, H., Liu, S., et al. Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging. Neuroimage 78 (2013), 68–74.
29. [29] Stuber, C., Morawski, M., Schafer, A., et al. Myelin and iron concentration in the human brain: a quantitative study of MRI contrast. Neuroimage 93 (2014), 95–106.
30. [30] Rizzo, G., Tonon, C., Manners, D., et al. Imaging brain functional and metabolic changes in restless legs syndrome. Curr Neurol Neurosci Rep, 13, 2013, 372.
31. [31] Oz, G., Alger, J.R., Barker, P.B., et al. Clinical proton MR spectroscopy in central nervous system disorders. Radiology 270 (2014), 658–679.
32. [32] Govindaraju, V., Young, K., Maudsley, A.A., Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 13 (2000), 129–153.
33. [33] Mekle, R., Mlynárik, V., Gambarota, G., et al. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T. Magn Reson Med 61 (2009), 1279–1285.
34. [34] Tkác, I., Oz, G., Adriany, G., et al. In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T. Magn Reson Med 62 (2009), 868–879.
35. 1H NMR spectroscopy of the human brain at 9.4 T: initial results. J Magn Reson 206 (2010), 74–80.
36. [36] Ashburner, J., Friston, K.J., Voxel-based morphometry – the methods. Neuroimage 11 (2000), 805–821.
37. [37] Fischl, B., Sereno, M.I., Tootell, R.B., et al. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 8 (1999), 272–284.
38. [38] Desikan, R.S., Segonne, F., Fischl, B., et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31 (2006), 968–980.
39. [39] Destrieux, C., Fischl, B., Dale, A., et al. Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature. Neuroimage 53 (2010), 1–15.
40. [40] Beaulieu, C., The basis of anisotropic water diffusion in the nervous system – a technical review. NMR Biomed 15 (2002), 435–455.
41. [41] Smith, S.M., Jenkinson, M., Johansen-Berg, H., et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31 (2006), 1487–1505.
42. [42] Jbabdi, S., Johansen-Berg, H., Tractography: where do we go from here?. Brain Connect 1 (2011), 169–183.
43. [43] Ogawa, S., Menon, R.S., Tank, D.W., et al. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys J 64 (1993), 803–812.
44. [44] van den Heuvel, M.P., Hulshoff Pol, H.E., Exploring the brain network: a review on resting-state fMRI functional connectivity. Eur Neuropsychopharmacol 20 (2010), 519–534.
45. [45] Friston, K.J., The disconnection hypothesis. Schizophr Res 30 (1998), 115–125.
46. [46] Calhoun, V.D., Adali, T., Pearlson, G.D., et al. A method for making group inferences from functional MRI data using independent component analysis. Hum Brain Mapp 14 (2001), 140–151.
47. [47] Cordes, D., Haughton, V., Carew, J.D., et al. Hierarchical clustering to measure connectivity in fMRI resting-state data. Magn Reson Imaging 20 (2002), 305–317.
48. [48] Thirion, B., Dodel, S., Poline, J.B., Detection of signal synchronizations in resting-state fMRI datasets. Neuroimage 29 (2006), 321–327.
49. [49] van den Heuvel, M., Mandl, R., Hulshoff Pol, H., Normalized cut group clustering of resting-state FMRI data. PLoS ONE, 3, 2008, e2001.
50. [50] Fornito, A., Zalesky, A., Breakspear, M., The connectomics of brain disorders. Nat Rev Neurosci 16 (2015), 159–172.
51. [51] Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15 (2002), 273–289.
52. [52] Fornito, A., Zalesky, A., Bullmore, E.T., Network scaling effects in graph analytic studies of human resting-state FMRI data. Front Syst Neurosci, 4, 2010, 22.
53. [53] Bullmore, E., Sporns, O., Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 10 (2009), 186–198.
54. [54] Zalesky, A., Fornito, A., Bullmore, E.T., Network-based statistic: identifying differences in brain networks. Neuroimage 53 (2010), 1197–1207.
55. [55] Filippi, M., van den Heuvel, M.P., Fornito, A., et al. Assessment of system dysfunction in the brain through MRI-based connectomics. Lancet Neurol 12 (2013), 1189–1199.
56. [56] Trenkwalder, C., Walters, A.S., Hening, W.A., et al. Positron emission tomographic studies in restless legs syndrome. Mov Disord 14 (1999), 141–145.
57. [57] San Pedro, E.C., Mountz, J.M., Mountz, J.D., et al. Familial painful restless legs syndrome correlates with pain dependent variation of blood flow to the caudate, thalamus, and anterior cingulate gyrus. J Rheumatol 25 (1998), 2270–2275.
58. [58] Eisensehr, I., Wetter, T.C., Linke, R., et al. Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology 57 (2001), 1307–1309.
59. [59] Tribl, G.G., Asenbaum, S., Klosch, G., et al. Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome. Neurology 59 (2002), 649–650.
60. [60] Michaud, M., Soucy, J.P., Chabli, A., et al. SPECT imaging of striatal pre and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol 249 (2002), 164–170.
61. [61] Linke, R., Eisensehr, I., Wetter, T.C., et al. Presynaptic dopaminergic function in patients with restless legs syndrome: are there common features with early Parkinson's disease?. Mov Disord 19 (2004), 1158–1162.
62. [62] Mrowka, M., Jobges, M., Berding, G., et al. Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndrome. J Neural Transm 112 (2005), 693–701.
63. 99mTc-TRODAT-1 SPECT as a potential neuroimaging biomarker in patients with restless legs syndrome. Clin Nucl Med 4 (2016), e14–17.
64. [64] Kim, K.W., Jhoo, J.H., Lee, S.B., et al. Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients. Eur J Neurol 19 (2012), 1213–1218.
65. [65] Ruottinen, H.M., Partinen, M., Hublin, C., et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 54 (2000), 502–504.
66. [66] Turjanski, N., Lees, A.J., Brooks, D.J., Striatal dopaminergic function in restless legs syndrome. 18F-dopa and 11C-raclopride PET studies. Neurology 52 (1999), 932–937.
67. [67] Earley, C.J., Kuwabara, H., Wong, D.F., et al. The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome. Sleep 34 (2011), 341–347.
68. [68] Staedt, J., Stoppe, G., Kögler, A., et al. Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus). J Neural Transm 93 (1993), 71–74.
69. [69] Staedt, J., Stoppe, G., Kögler, A., et al. Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. Eur Arch Psychiatry Clin Neurosci 245 (1995), 8–10.
70. [70] Staedt, J., Stoppe, G., Kögler, A., et al. Single photon emission tomography (SPET) imaging of dopamine D2-receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). J Neural Transm 99 (1995), 187–193.
71. [71] Earley, C.J., Kuwabara, H., Wong, D.F., et al. Increased synaptic dopamine in the putamen in restless legs syndrome. Sleep 36 (2013), 51–57.
72. [72] Oboshi, Y., Ouchi, Y., Yagi, S., et al. In vivo mesolimbic D2/3 receptor binding predicts post therapeutic clinical responses in restless legs syndrome: a positron emission tomography study. J Cereb Blood Flow Metab 32 (2012), 654–662.
73. [73] Cervenka, S., Pålhagen, S.E., Comley, R.A., et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 129 (2006), 2017–2028.
74. 11C]diprenorphine PET study. Brain 128 (2005), 906–917.
75. [75] Jhoo, J.H., Yoon, I.Y., Kim, Y.K., et al. Availability of brain serotonin transporters in patients with restless legs syndrome. Neurology 74 (2010), 513–518.
76. [76] Allen, R.P., Barker, P.B., Wehrl, F., et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 56 (2001), 263–265.
77. [77] Earley, C.J., B Barker, P., Horska, A., et al. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med 7 (2006), 458–461.
78. [78] Margariti, P.N., Astrakas, L.G., Tsouli, S.G., et al. Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours. AJNR Am J Neuroradiol 33 (2012), 667–672.
79. [79] Moon, H.J., Chang, Y., Lee, Y.S., et al. T2 relaxometry using 3.0-tesla magnetic resonance imaging of the brain in early- and late-onset restless legs syndrome. J Clin Neurol 10 (2014), 197–202.
80. [80] Godau, J., Klose, U., Di Santo, A., et al. Multiregional brain iron deficiency in restless legs syndrome. Mov Disord 23 (2008), 1184–1187.
81. [81] Rizzo, G., Manners, D., Testa, C., et al. Low brain iron content in idiopathic Restless Legs Syndrome patients detected by phase imaging. Mov Disord 28 (2013), 1886–1890.
82. [82] Li, X., Liu, H., Allen, R.P., et al. Assessment of brain iron deficiency in restless legs syndrome (RLS) using quantitative susceptibility mapping at 7T. 2014, ISMRM, Milan, Italy, 3270.
83. [83] Li, X., Liu, H., Allen, R.P., et al. Quantitative susceptibility mapping (QSM) indicates possible iron deficiency in the thalamus and dentate nucleus in restless legs syndrome (RLS). 2015, ISMRM, Toronto, Canada, 1736.
84. [84] Knake, S., Heverhagen, J.T., Menzler, K., et al. Normal regional brain iron concentration in restless legs syndrome measured by MRI. Nat Sci Sleep 2 (2009), 19–22.
85. [85] Astrakas, L.G., Konitsiotis, S., Margariti, P., et al. T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome. Neurology 71 (2008), 911–916.
86. [86] Moon, H.J., Chang, Y., Lee, Y.S., et al. A comparison of MRI tissue relaxometry and ROI methods used to determine regional brain iron concentrations in restless legs syndrome. Med Devices (Auckl) 8 (2015), 341–350.
87. [87] Schmidauer, C., Sojer, M., Seppi, K., et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 58 (2005), 630–634.
88. [88] Godau, J., Schweitzer, K.J., Liepelt, I., et al. Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome. Mov Disord 22 (2007), 187–192.
89. [89] Godau, J., Wevers, A.K., Gaenslen, A., et al. Sonographic abnormalities of brainstem structures in restless legs syndrome. Sleep Med 9 (2008), 782–789.
90. [90] Ryu, J.H., Lee, M.S., Baik, J.S., Sonographic abnormalities in idiopathic restless legs syndrome (RLS) and RLS in Parkinson's disease. Parkinsonism Relat Disord 17 (2011), 201–203.
91. [91] Rizzo, G., Tonon, C., Testa, C., et al. Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome. Brain 135 (2012), 3712–3720.
92. [92] Allen, R.P., Barker, P.B., Horská, A., et al. Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep. Neurology 80 (2013), 2028–2034.
93. [93] Winkelman, J.W., Schoerning, L., Platt, S., et al. Restless legs syndrome and central nervous system gamma-aminobutyric acid: preliminary associations with periodic limb movements in sleep and restless leg syndrome symptom severity. Sleep Med 15 (2014), 1225–1230.
94. [94] Etgen, T., Draganski, B., Ilg, C., et al. Bilateral thalamic gray matter changes in patients with restless legs syndrome. Neuroimage 24 (2005), 1242–1247.
95. [95] Celle, S., Roche, F., Peyron, R., et al. Lack of specific gray matter alterations in restless legs syndrome in elderly subjects. J Neurol 257 (2010), 344–348.
96. [96] Comley, R.A., Cervenka, S., Palhagen, S.E., et al. A comparison of gray matter density in restless legs syndrome patients and matched controls using voxel-based morphometry. J Neuroimaging 22 (2012), 28–32.
97. [97] Rizzo, G., Manners, D., Vetrugno, R., et al. Combined brain voxel-based morphometry and diffusion tensor imaging study in idiopathic restless legs syndrome patients. Eur J Neurol 19 (2012), 1045–1049.
98. [98] Belke, M., Heverhagen, J.T., Keil, B., et al. DTI and VBM reveal white matter changes without associated gray matter changes in patients with idiopathic restless legs syndrome. Brain Behav, 5, 2015, e00327.
99. [99] Unrath, A., Juengling, F.D., Schork, M., et al. Cortical grey matter alterations in idiopathic restless legs syndrome: an optimized voxel-based morphometry study. Mov Disord 22 (2007), 1751–1756.
100. [100] Hornyak, M., Ahrendts, J.C., Spiegelhalder, K., et al. Voxel-based morphometry in unmedicated patients with restless legs syndrome. Sleep Med 9 (2007), 22–26.
101. [101] Connor, J.R., Ponnuru, P., Lee, B.Y., et al. Postmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndrome. Sleep Med 12 (2011), 614–619.
102. [102] Chang, Y., Chang, H.W., Song, H., et al. Gray matter alteration in patients with restless legs syndrome: a voxel-based morphometry study. Clin Imaging 39 (2015), 20–25.
103. [103] Unrath, A., Müller, H.P., Ludolph, A.C., et al. Cerebral white matter alterations in idiopathic restless legs syndrome, as measured by diffusion tensor imaging. Mov Disord 23 (2008), 1250–1255.
104. [104] Chang, Y., Paik, J.S., Lee, H.J., et al. Altered white matter integrity in primary restless legs syndrome patients: diffusion tensor imaging study. Neurol Res 36 (2014), 769–774.
105. [105] Lindemann, K., Müller, H.P., Ludolph, A.C., et al. Microstructure of the midbrain and cervical spinal cord in idiopathic restless legs syndrome: a diffusion tensor imaging study. Sleep 39:2 (2016), 423–428 pii: sp-00170-15; Epub ahead of print.
106. [106] Bucher, S.F., Seelos, K.C., Oertel, W.H., et al. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol 41 (1997), 639–645.
107. [107] Spiegelhalder, K., Feige, B., Paul, D., et al. Cerebral correlates of muscle tone fluctuations in restless legs syndrome: a pilot study with combined functional magnetic resonance imaging and anterior tibial muscle electromyography. Sleep Med 9 (2008), 177–183.
108. [108] Deco, G., Jirsa, V.K., McIntosh, A.R., Emerging concepts for the dynamical organization of resting-state activity in the brain. Nat Rev Neurosci 12 (2011), 43–56.
109. [109] Raichle, M.E., MacLeod, A.M., Snyder, A.Z., et al. A default mode of brain function. Proc Natl Acad Sci USA 98 (2001), 676–682.
110. [110] Hening, W.A., Walters, A.S., Wagner, M., et al. Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome. Sleep 22 (1999), 901–912.
111. [111] Ku, J., Cho, Y.W., Lee, Y.S., et al. Functional connectivity alternation of the thalamus in restless legs syndrome patients during the asymptomatic period: a resting-state connectivity study using functional magnetic resonance imaging. Sleep Med 15 (2014), 289–294.
112. [112] Liu, C., Dai, Z., Zhang, R., et al. Mapping intrinsic functional brain changes and repetitive transcranial magnetic stimulation neuromodulation in idiopathic restless legs syndrome: a resting-state functional magnetic resonance imaging study. Sleep Med 16 (2015), 785–791.
113. [113] Gorges, M., Rosskopf, J., Müller, H.P., et al. Patterns of increased intrinsic functional connectivity in patients with restless legs syndrome are associated with attentional control of sensory inputs. Neurosci Lett 617 (2016), 264–269.
114. [114] Ku, J., Lee, Y.S., Chang, H.W., et al. Default mode network disturbances in restless legs syndrome/Willis–Ekbom disease. Sleep Med 23 (2016), 6–11, 10.1016/j.sleep.2016.05.007.
115. [115] Allen, R.P., Earley, C.J., The role of iron in restless legs syndrome. Mov Disord 22 (2007), S440–8.
116. [116] Connor, J.R., Wang, X.S., Allen, R.P., et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain 132 (2009), 2403–2412.
117. [117] Ford, C.P., The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience 282C (2014), 13–22.
118. [118] Allen, R.P., Restless leg syndrome/Willis-Ekbom disease pathophysiology. Sleep Med Clin 10 (2015), 207–214 xi.
119. [119] Trenkwalder, C., Högl, B., Winkelmann, J., Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol 256 (2009), 539–553.
120. [120] Yu, G.S., Steinkirchner, T.M., Rao, G.A., et al. Effect of prenatal iron deficiency on myelination in rat pups. Am J Pathol 125 (1986), 620–624.
121. [121] Ortiz, E., Pasquini, J.M., Thompson, K., et al. Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 77 (2004), 681–689.
122. [122] Price, D.D., Psychological and neural mechanisms of the affective dimension of pain. Science 288 (2000), 1769–1772.
123. [123] Karroum, E.G., Golmard, J.L., Leu-Semenescu, S., et al. Sensations in restless legs syndrome. Sleep Med 13 (2012), 402–408.
124. [124] Winkelmann, J., Prager, M., Lieb, R., et al. “Anxietas tibiarum”. Depression and anxiety disorders in patients with restless legs syndrome. J Neurol 252 (2005), 67–71.
125. [125] Cho, S.J., Hong, J.P., Hahm, B.J., et al. Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep 32 (2009), 1069–1076.
126. [126] Hornyak, M., Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management. CNS Drugs 24 (2010), 89–98.
127. [127] Celle, S., Roche, F., Kerleroux, J., et al. Prevalence and clinical correlates of restless legs syndrome in an elderly French population: the synapse study. J Gerontol A Biol Sci Med Sci 65 (2010), 167–173.
128. [128] Pearson, V.E., Allen, R.P., Dean, T., et al. Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 7 (2006), 25–30.
129. [129] Gamaldo, C.E., Benbrook, A.R., Allen, R.P., et al. A further evaluation of the cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 9 (2008), 500–505.
130. [130] Fulda, S., Beitinger, M.E., Reppermund, S., et al. Short-term attention and verbal fluency is decreased in restless legs syndrome patients. Mov Disord 25 (2010), 2641–2648.
131. [131] Walters, A.S., Rye, D.B., Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep 32 (2009), 589–597.
132. [132] Connor, J.R., Patton, S., Oexle, K., et al. Iron and RLS: treatment, genetics and pathophysiology. Sleep Med 31 (2017), 61–70.